Evidence map›Paper›PMID 41844611›Full record

ArticleNature communications2026

A blueprint for local and distal invasion programs in glioblastoma.

Rony Chanoch-Myers, Toshiro Hara, Alissa C Greenwald, Rouven Hoefflin, Lillian Bussema, Hannah R Weisman, Edwin Nieblas-Bedolla, Jahnavi Gurramkonda, Zhibek Bekezhankyzy, Alexander Jucht and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Rony Chanoch-Myers *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Toshiro Hara *Broad Institute of Harvard and MIT, Cambridge, MA, USA. hara@umich.edu.ORCID http://orcid.org/0000-0002-4389-3393
Alissa C Greenwald *Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Rouven HoefflinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Lillian BussemaBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5469-3816
Hannah R WeismanBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0009-0008-0493-9265
Edwin Nieblas-BedollaDepartment of Neurosurgery and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-5879-1800
Jahnavi GurramkondaDepartment of Neurosurgery and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0009-0007-3374-606X
Zhibek BekezhankyzyDepartment of Neurosurgery and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.
Alexander JuchtBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0009-0004-9384-804X
Ester Calvo FernándezBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Avishay SpitzerDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-6551-9338
Jeremy Man Hon FungDepartment of Pathology and Krantz-Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Biella ChiaraNeural Stem Cell Biology Unit, Division of Neuroscience, IRCCS San Raffaele Hospital, Via Olgettina, Milan, Italy.
Wajd N Al-HolouDepartment of Neurosurgery and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.
Sandra Camelo-PiraguaDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
Jinan BehnanThe Leo M. Davidoff Department of Neurological Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.ORCID http://orcid.org/0000-0001-5780-0971
Rossella GalliNeural Stem Cell Biology Unit, Division of Neuroscience, IRCCS San Raffaele Hospital, Via Olgettina, Milan, Italy.ORCID http://orcid.org/0000-0001-9023-7033
Hiroaki WakimotoDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8225-241X
Mario L SuvàBroad Institute of Harvard and MIT, Cambridge, MA, USA. Suva.Mario@mgh.harvard.edu.
Itay TiroshDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Itay.tirosh@weizmann.ac.il.ORCID http://orcid.org/0000-0001-5477-2987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma invasion into brain parenchyma presents significant challenges for treatment but remains poorly understood. In this study, we combine single-cell RNA sequencing, spatial transcriptomics, and multiplexed imaging of orthotopic xenograft models to investigate glioblastoma invasion. We first screen 20 patient-derived gliomasphere models for their distal (i.e., extending to the contralateral hemisphere) and local invasive potential in mice. We show that models with distal invasion potential are enriched with oligodendrocyte progenitor-like cells, while models with only local invasion potential are enriched with mesenchymal-like cells. These patterns reflect predominantly peri-axonal vs peri-vascular invasion routes, respectively. Next, we analyze the transcriptomes of invading cells within models (compared to tumor core) and identify programs associated with distal and local invasion. Thus, we decouple transcriptional features associated with invasion potential from those associated with the process of invasion. We validate our findings by spatial transcriptomics and multiplexed imaging, further describing the spatial niche of invasive cells. Taken together, our results provide a blueprint for the invasive potential of glioblastoma cell states and of the programs associated with invasion across different scales.

Indexed as

Brain NeoplasmsGlioblastomaNeoplasm InvasivenessAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMiceSingle-Cell AnalysisSpatial TranscriptomicsTranscriptome

Identifiers

PMID41844611
PMCPMC13144537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.